Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for over 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic diseases, infectious diseases and rare diseases.
Shared 2 weeks ago
255 views
Shared 2 weeks ago
272 views
Shared 3 weeks ago
317 views
Shared 1 month ago
342 views
Shared 1 month ago
177 views
Shared 1 month ago
203 views
Shared 2 months ago
140 views
Shared 3 months ago
254 views
Shared 5 months ago
473K views
Shared 5 months ago
200 views
Shared 5 months ago
82 views
Shared 6 months ago
419 views
Shared 6 months ago
1.1K views
Shared 7 months ago
381 views
Shared 8 months ago
410 views
Shared 8 months ago
145 views
Shared 9 months ago
41K views
Shared 9 months ago
306 views
Shared 9 months ago
103K views
Shared 1 year ago
777 views
Shared 1 year ago
160 views
Shared 1 year ago
449 views
Shared 1 year ago
18K views
Shared 1 year ago
23K views
Shared 1 year ago
343 views
Shared 1 year ago
669 views
Shared 1 year ago
460 views
Shared 1 year ago
338 views